Komatsu, Japan

Kiyoshi Akiyama

This inventor holds 8 USPTO granted patents, plus 4 CIPO patents and 4 EPO patents. Top assignee: Ohgen Research Laboratories, Ltd.. Active years: 1993-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kiyoshi Akiyama. Retrieved from https://idiyas.com/inventor/kiyoshi-akiyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0



Average Co-Inventor Count = 1.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1993-2009

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Kiyoshi Akiyama: Innovator in Antitumor Compounds

Introduction

Kiyoshi Akiyama is a notable inventor based in Komatsu, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with antitumor activity. With a total of 8 patents to his name, Akiyama's work has the potential to impact cancer treatment positively.

Latest Patents

Akiyama's latest patents include innovative compounds that demonstrate excellent antitumor activity. One of his notable inventions involves geranyl compounds, which are represented by specific chemical formulae. Another significant contribution is related to mevalonic acid derivatives, which also exhibit promising antitumor properties.

Career Highlights

Kiyoshi Akiyama is currently associated with Ohgen Research Laboratories, Ltd. His work at this organization has allowed him to focus on the synthesis and application of novel compounds aimed at combating cancer. His dedication to research and development has positioned him as a key figure in his field.

Conclusion

Kiyoshi Akiyama's innovative work in developing antitumor compounds showcases his commitment to advancing medical science. His contributions through his patents reflect a significant step forward in cancer research and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…